Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation Study

Background GLACIER (Giving Long-Acting Cabotegravir plus rilpivirine [CAB + RPV LA] in an Infusion Center [IC]) is a Phase 4 implementation study evaluating the perspective of people living with HIV-1 (participants) and IC staff on CAB + RPV LA delivery at ICs over 8 months. Methods Participants and...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Cassidy A. Gutner PhD, Conn Harrington BA, Gilda Bontempo MD, Sivakumar Pazhamalai BPharm, Abhishek Kumar MSc, Kelly Rimler MS, Karen Davis MS, RN, Will Williams BS, Deanna Merrill PharmD, MBA, AAHIVP, Lisa Petty MT (ASCP), Cindy Garris MS, Supriya Sarkar PhD, MPH, Patrick Daniele MS, Bridget Gaglio PhD, MPH, Katie May BSN, Michael Aboud MBChB, Maggie Czarnogorski MD, MPH
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	SAGE Publishing 2026-05-01
Reeks:	Journal of the International Association of Providers of AIDS Care
Online toegang:	https://doi.org/10.1177/23259582261439585
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!